SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentrations Risks (Details) - item |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Concentration Risk [Line Items] | |||
| Number of major suppliers | 2 | ||
| Revenues | Customer concentration | China Resources Pharmaceutical Commercial Group International Trading Co., Ltd. | |||
| Concentration Risk [Line Items] | |||
| Concentration risk percentage | 90.20% | 98.10% | 100.00% |
| Accounts receivable | Customer concentration | China Resources Pharmaceutical Commercial Group International Trading Co., Ltd. | |||
| Concentration Risk [Line Items] | |||
| Concentration risk percentage | 69.50% | 98.80% | 100.00% |
| X | ||||||||||
- Definition Number of major suppliers, where each supplier accounting over 10% of supplies. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|